StarTribune
Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immune Pharmaceuticals may spinoff Cytovia

By: MarketMinute.com Stock News

Immune Pharmaceuticals Inc. (Nasdaq: IMNP) named Dr. Daniel Teper to lead the oncology business of its Cytovia subsidiary and to pursue a potential spin-off of Cytovia. The stock price dropped 74 cents to close at $2.79.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
Browse Business Sections
Latest Columns
Elsewhere in Business
  1. 6m
    Despite numbers showing a healthy economy overall, lower-income spenders are showing the strain
  2. 10m
    Average long-term US mortgage rate snaps five-week string of increases, but remains above 7%
  3. 17m
    Argentina labor unions' 1-day strike against President Milei paralyzes daily life
  4. 21m
    TikTok to start labeling AI-generated content as technology becomes more universal
  5. 21m
    Chevrolet Malibu heads for the junkyard as GM shifts focus to electric vehicles
  6. 2h
    Top public relations executive at Chinese technology firm Baidu apologizes after sparking backlash
  7. 2h
    Asteroids, Myst, Resident Evil, SimCity and Ultima inducted into World Video Game Hall of Fame
  8. 3h
    Stock market today: Wall Street is off to a mixed start
  9. 3h
    Ramón Fonseca, partner in firm at center of "Panama Papers" scandal, dies
  10. 4h
    US weekly jobless claims rise to highest level since August of 2023
Most Read
  1. Murals, loans and grants aid Lake Street's recovery, but years of work remain • Business
  2. Also at stake in the Timberwolves, Lynx ownership dispute: Financial damages • Business
  3. Where Lake Street rebuilding projects stand four years after the riots • Business
  4. Lower car prices bring better deals, but high interest rates deter some Minnesota buyers • Business
  5. Minneapolis Fed's Kashkari says interest rate conundrum makes 2024 uncertain • Business

Business

Complete coverage of business news in the Twin Cities, Minnesota and elsewhere, including Fortune 500 Minnesota companies: UnitedHealth Group, Target, Best Buy, 3M, CHS, U.S. Bancorp, General Mills, C.H. Robinson, Land O’Lakes, Ecolab, Ameriprise Financial, Xcel Energy, Hormel Foods, Thrivent Financial, Polaris, Securian Financial Group, Fastenal and Patterson Cos.

© 2024 StarTribune. All rights reserved.